Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Guiding principles for pragmatic randomised trials of tuberculosis treatments.
Journal: The Lancet. Infectious diseases
Published: March 30, 2026
Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 13, 2025
Experience with Linezolid for the Treatment of Rifampin-Susceptible Tuberculosis in San Francisco.
Journal: Open forum infectious diseases
Published: October 22, 2025
Tuberculosis Disease Severity Assessment Using Clinical Variables and Radiology Enabled by Artificial Intelligence.
Journal: The Journal of infectious diseases
Published: August 27, 2025
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
Journal: medRxiv : the preprint server for health sciences
Published: August 08, 2025
Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 28, 2025
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Journal: Nature communications
Published: May 13, 2025
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis.
Journal: Research square
Published: April 08, 2025
Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: March 29, 2025
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.
Journal: Trials
Published: January 30, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Journal: The New England journal of medicine
Published: January 29, 2025
Person-centred language for describing stratified approaches to TB treatment.
Journal: IJTLD open
Published: November 07, 2024
Last Updated: 09/26/2026